« Previous
Next »
Cancer Letters
Volume 234, Issue 2
, Pages 184-192
, 28 March 2006
Expression of candidate chromosome 3p21.3 tumor suppressor genes and down-regulation of BLU in some esophageal squamous cell carcinomas
References
- . Allelotype study of esophageal carcinoma. Genes Chromosomes Cancer. 1994;10:177–182
- . Frequent microsatellite alterations on chromosome 3p in esophageal squamous cell carcinoma. Cancer Research. 1995;55:891–894
- . Frequent loss of heterozygosity on multiple chromosomes in Chinese esophageal squamous cell carcinomas. Cancer Letters. 2001;170:131–138
- Cytogenetic heterogeneity and progression of esophageal squamous cell carcinoma. Cancer Genetics and Cytogenetics. 2003;147:50–61
- Interstitial deletions including chromosome 3 common eliminated region 1 (C3CER1) prevail in human solid tumors from 10 different tissues. Genes Chromosomes and Cancer. 2004;41:232–242
- High-resolution chromosome 3p allelotyping of breast carcinomas and precursor lesions demonstrates frequent loss of heterozygosity and a discontinuous pattern of allele loss. Am. J. Pathol. 2001;159:119–130
- . Functional evidence for a nasopharyngeal carcinoma tumor suppressor gene that maps at chromosome 3p21.3. Proceedings of the National Academy of Sciences USA. 1998;95:3042–3047
- . The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium. Cancer Research. 2000;60:6116–6133
- Analysis of suppressive roles of BLU gene at 3p21.3 in nasopharyngeal carcinoma. Ai Zheng. 2003;22:128–135
- . Frequent epigenetic inactivation of RASSF1A and BLU genes located within the critical 3p21.3 region in gliomas. Oncogene. 2004;23:2408–2419
- The candidate tumor suppressor gene BLU, located at the commonly deleted region 3p21.3, is an E2F-regulated, stress-responsive gene and inactivated by both epigenetic and genetic mechanisms in nasopharyngeal carcinoma. Oncogene. 2004;23:4793–4806
- Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers. Oncogene. 2003;22:1580–1588
- Establishment, characterization, karyotyping, and comparative genomic hybridization analysis of HKESC-2 and HKESC-3: two newly established human esophageal squamous cell carcinoma cell lines. Cancer Genetics and Cytogenetics. 2002;35:120–127
- Establishment and characterization of a new xenograft-derived human esophageal squamous cell carcinoma cell line SLMT-1 of Chinese origin. Cancer Genetics and Cytogenetics. 2001;124:36–41
- Biologic properties of three newly established human esophageal carcinoma cell lines. Journal of the National Cancer Institute. 1984;72:577–583
- . A case of esophageal carcinoma metastatic to the mandible and characterization of two cell lines (T-T and T-Tn) established from the oral tumor. Japanese Journal of Oral and Maxillofacial Surgery. 1990;36:307–316
- . Preparation of genomic DNA from mammalian tissue. In: Ausubel FM, Brent R, Kingston RE, Moore DD, Seidman JG, Smith JA, Strunl K editor. Current Protocols in Molecular Biology. vol. 1:New York: Wiley; 1989;p. 221–223
- Epigenetic inactivation of the candidate 3p21.3 suppressor gene BLU in human cancers. Oncogene. 2003;13:1580–1588
- . Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) Method. Methods. 2001;25:402–408
- Alterations of BLU, a candidate tumor suppressor gene on chromosome 3p21.3, in human nasopharyngeal carcinoma. International Journal of Cancer. 2003;10:60–65
- . Promoter hypermethylation of RASSF1A in esophageal squamous cell carcinoma. Clinical Cancer Research. 2003;9:1441–1445
- Allelic loss on chromosome 3p21.3 and promoter hypermethylation of semaphorin 3B in non-small cell lung cancer. Cancer Research. 2003;15:3352–3355
- Real-time quantification of CK-19 mRNA-positive cells in peripheral blood of breast cancer patients using the lightcycler system. Clinical Cancer Research. 2003;9:5145–5151
- A 3p21.3 region is preferentially eliminated from human chromosome 3/mouse microcell hybrids during tumor growth in SCID mice. Genes, Chromosomes and Cancer. 1997;18:200–211
- Human/mouse microcell hybrid based elimination test reduces the putative tumor suppressor region at 3p21.3 to 1.6 cM. Genes, Chromosomes and Cancer. 1997;20:329–336
- Similar regions of human chromosome 3 are eliminated from or retained in human/human and human/mouse microcell hybrids during tumor growth in severe combined immunodeficient (SCID) mice. Proceedings of the National Academy of Sciences USA. 2001;98:1136–1141
- . Haploinsufficiency for tumour suppressor genes: when you don't need to go all the way. Biochimica et Biophysica Acta. 2004;1654:105–122
- . Hypermethylation of RASSF1A and BLU tumor suppressor genes in non-small cell lung cancer: implications for tobacco smoking during adolescence. International Journal of Cancer. 2005;114:219–223
- . Tumor suppressor genes on chromosome 3p involved in the pathogenesis of lung and other cancers. Oncogene. 2002;21:6915–6935
- RASSF1A is a target tumor suppressor from 3p21.3 in nasopharyngeal carcinoma. International Journal of Cancer. 2004;109:839–847
- Expression of several genes in the human chromosome 3p21.3 homozygous deletion region by an adenovirus vector results in tumor suppressor activities in vitro and in vivo. Cancer Research. 2002;62:2715–2720
- . Perspectives on classic article: metastasis suppressor genes. Journal of National Cancer Institute. 2004;96:E4
PII: S0304-3835(05)00288-0
doi: 10.1016/j.canlet.2005.03.036
© 2005 Elsevier Ireland Ltd. All rights reserved.
« Previous
Next »
Cancer Letters
Volume 234, Issue 2
, Pages 184-192
, 28 March 2006
